Sri Ryali | Chief Financial Officer |
David Cory | President and Chief Executive Officer |
Ingrid Choong | Senior Vice President-Clinical Development |
Eldon Mayer | Chief Commercial Officer |
Colin Hislop | Senior Vice President-Clinical and Development Operations |
Bert Hazlett | BTIG |
Ashiq Mubarack | Citi |
Maury Raycroft | Jefferies |
Brian Skorney | Baird |
Michael Higgins | Ladenburg Thalmann |
Good day, ladies and gentlemen, and welcome to the Eiger BioPharmaceuticals’ Third Quarter 2021 Financial Results and Business Update Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at the time. [Operator Instructions] As a reminder, this call will be recorded. I would now like to introduce your host for today, Mr.